查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138306

全球医用特种袋市场-2022-2029

Global Medical Specialty Bags Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球医疗专用袋市场的增长受到某些因素的推动，例如造口术等外科手术的增加。结肠癌、憩室炎和 IBD 等几种疾病的发病率不断上升，推动对外科手术的需求是推动市场增长的关键因素之一。

预计外科手术的增加将在预测期内推动全球医疗专用袋市场。

手术涉及大量出血，需要输血，所以用于血液及血液成分运输、肾透析、采集、处理、储存等的专用医用袋的采用率很高。我是这里。因此，在预测期内，增加手术、透析和输血程序预计将推动市场增长。

不断增长的老年人口是尿失禁发病率增加的主要因素之一，预计将推动对尿液收集袋的需求。由于老年人容易出现尿失禁，对医疗专用袋的需求正在增加。根据疾病控制和预防中心 (CDC) 的数据，慢性肾脏病 (CKD) 在 65 岁以上的人群中 (38%) 比在 45-64 岁 (13%) 和 18-44 岁 (7 %）。由于人口结构的持续变化，一些国家正面临挑战。根据联合国经济和社会事务部人口司的数据，2017 年，世界 60 岁人口预计在未来 30 年内翻一番，而 80 岁人口预计将增加两倍。

此外，由于医疗保健领域技术的进步和医疗设施的扩大，预计医疗专用袋市场将在预测期内显着增长。卫生和健康意识的提高正在推动医疗专用袋市场的增长。此外，政府组织增加支持将对市场增长产生积极影响，因为它将鼓励对医疗基础设施的投资、有利的报销政策以及鼓励研发活动。

COVID-19 影响分析

随着 COVID-19 的爆发，实验室正在加紧研发，以寻找可以及早减轻冠状病毒症状的解决方案。已确定静脉注射免疫球蛋白和 LMWH（低分子量肝素）抗凝剂有望改善 COVID-19 的预后。因此，输液袋和其他医疗专用袋市场的公司已经註意到了这一趋势，并正在努力在 COVID-19 爆发期间提高其生产能力。静脉注射免疫球蛋白治疗和LMWH抗凝可减少外周血淋巴细胞和B淋巴细胞，从而改善患者。在 COVID-19 患者中启动静脉注射免疫球蛋白和 LMWH 抗凝剂预计将为特种医疗袋製造商创造收入机会。然而，由于 COVID-19，原材料供应和供应延迟是包装製造商目前在市场上面临的一些挑战。

行业分析

全球医用特种袋市场基于波特五力分析、供应链分析、监管分析、价格分析、流行病学、管道分析、未满足需求等各种行业因素提供分析。

全球医疗专用袋市场报告提供了大约 40 多个市场数据表、45 多个数字和 180 页的结构。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
  • 驱动程序
    • 增加手术、透析和输血程序
    • 易患尿失禁的老年人增多
  • 限制因素
    • 缺乏保险报销
  • 商机
  • 影响分析

第5章行业分析

  • 波特五力分析
  • 流行病学
  • 管道分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 未满足的需求

第 6 章按产品分类

  • 尿袋
  • 持续不卧床腹膜透析 (CAPD) 袋
  • 麻醉用呼吸袋
  • 血袋
  • 造口用尿液收集袋
    • 一次性袋子
    • 多用袋
  • 肠内营养袋
  • 胆汁收集袋
  • 无菌包装袋
  • 復苏包
    • 一次性袋子
    • 可重复使用的袋子
  • 滴水袋
    • PVC袋
    • 非氯乙烯输液袋
  • 尸袋
  • 灌肠袋
  • 冰袋

第 7 章最终用户的构成比

  • 医院
  • 手术中心
  • 保健中心
  • 家庭保健
  • 其他

第 8 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 9 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 10 章公司简介

  • B.Braun Melsungen AG
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Baxter International Inc.
  • Coloplast AS
  • ConvaTec Group Plc
  • Hollister Inc.
  • Becton, Dickinson, and Co.
  • Cardinal Health Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Terumo Corporation
  • Kawasumi Laboratories Inc（List Not Exhaustive）

第11章 DataM

简介目录
Product Code: DMHOS2611

Market Overview

Medical specialty bags market size was valued at US$ 10.44 billion in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.9% during the forecast period (2022-2029).

Medical specialty bags are used in various applications such as urine collection, blood storage, bile collection, enteral feeding, sterile packaging, among others. These collection bags are manufactured with advanced materials to enhance their quality and are used to avoid any contamination. These medical specialty bags are highly used in hospitals to prevent the risk of any disease or infection. The rising demand for aseptic conditions in the medical institutes has increased the popularity of medical specialty bags globally.

Market Dynamics

The global medical specialty bags market growth driven by certain factors such as by increasing surgical procedures, such as ostomy procedures. The increasing incidence of several disorders such as colorectal cancer, diverticulitis, and IBD is driving the demand for surgical procedures are among the key factors driving the market growth.

Increasing surgical procedures, is expected to drive the global medical specialty bags market during the forecast period

The surgical procedures involve a lot of blood loss, and there is a need for blood transfusions, which is leading to higher adoption of medical specialty bags as these are used for the transfer of blood and blood components, renal dialysis and collection, processing, and storage. Therefore, the increasing number of surgical procedures, dialysis, and blood transfusion procedures are expected to stimulate market growth over the forecast period.

The growing geriatric population is one of the major factors responsible for the increase in incidences of urinary incontinence which is expected to drive the demand for urinary collection bags. Since the aged population is more prone to urinary incontinence, the demand for medical specialty bags is increasing. Chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%) according to Centers for Disease Control and Prevention (CDC). Several countries are facing challenges due to the ongoing and increasing demographic shift in age among their people. According to the Department of Economic and Social Affairs Population Division of United Nations, 2017, the world's population who are 60 years old will double and those of 80 years old will triple during the next 30 years.

Furthermore, the medical specialty bags market is expected to grow significantly over the forecast period due to the increasing technological advancements in the healthcare sector and improved medical facilities. The increasing awareness of hygiene and health is fuelling the growth of the medical specialty bags market. Also, growing support from government organizations positively affects market growth since they facilitate investments in the healthcare infrastructure, favorable reimbursement policies, and encouraging research and development activities.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, research labs have increased their research & development to find solutions that can minimize the symptoms of coronavirus at early stages. It is observed that the intravenous immunoglobulin and LMWH (Low-molecular-weight heparin) anticoagulant therapy holds promising potentials in improving the COVID-19 prognosis. Hence, companies in the IV bags and other medical specialty bags market are focusing on this trend and increasing their efforts to boost the production capabilities amidst the COVID-19 pandemic. Intravenous immunoglobulin and LMWH anticoagulant therapy can lower the lymphocytes and B lymphocytes in peripheral blood, resulting in improvements in patients. The initiation of IV immunoglobulin and LMWH anticoagulant therapy in COVID-19 patients is projected to create revenue opportunities for manufacturers of medical specialty bags. However, lack of raw material availability and delayed supplies are some of the challenges that packaging manufacturers are currently facing in the market due to COVID-19.

Industry Analysis

The global medical specialty bags market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, epidemiology, pipeline analysis, unmet needs.

Segment Analysis

The ostomy collection bags segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Based on product, the global medical specialty bags market is segmented into urinary collection bags, continuous ambulatory peritoneal dialysis (CAPD) bags, anesthesia breathing bags, blood bags, ostomy collection bags, enteral feeding bags, bile collection bags, sterile packaging bags, resuscitation bags, intravenous fluid bags, cadaver bags, enema bags, and ice bags. Among these, the ostomy collection bags is estimated to dominated the global medical specialty bags market during the forecast period. These are available in either single-use bags or multiple-use bags. The SenSura Mio Baby ostomy bag manufactured by Coloplast is characterized by its long wear time, which ensures that premature babies are not disturbed. The bag adhesive is designed for sensitive skin and easy reuse. It stays on the baby's belly when the bag is changed. The SenSura Mio Kids ostomy bag is covered in a skin-friendly textile and discreet under clothing.

The Intravenous fluid bags are estimated to grow at the fastest growth rate over the forecast period, due to their various applications such as maintaining the correct electrolyte imbalance, sustaining and balancing the basal hydration level, and expanding IV volumes hypovolemic state in patients. Also, IV fluid bags are used in various healthcare processes along with the convenience and ease with to provide nutrition to any patient. However, the IV bags market is expected to experience a few challenges owing to the consequences of sterilizing IV bags. Also, with growing environmental impacts associated with the use of PVC, demand is anticipated to shift towards non-PVC material over the forecast period.

The IV bags market is predicted to reach an output of over 5,000 units by the end of 2027. However, a shortage of IV fluids in the U.S. healthcare system is likely to hamper the market for IV bags. Hence, pharmaceutical companies are adopting several strategies to strengthen their supply chains in the U.S. For instance, B. Braun has launched its Solutions for Life initiative by investing in IV therapy manufacturing facilities to ensure long-term supplies for the U.S. healthcare systems. Such initiatives are helpful for companies in the IV bags market.

Geographical Analysis

North America region holds the largest market share of the global medical specialty bags market

North America region is dominating the global Medical Specialty Bags market accounted for the largest market share in 2021, owing to rising incidences of chronic disorders and increasing surgical procedures which increases the demand for medical specialty bags. As per the National Association for Incontinence (NAFC), in North America, nearly 200 million people are affected by urinary incontinence. The United States and Canada are the key contributing regions for medical specialty bags in North America, owing to well-established healthcare infrastructure and favorable reimbursement policies in these countries.

Competitive Landscape

The medical specialty bags market is highly competitive and consists of several major players and the emergence of new players in the market. Some of the key players which are contributing to the growth of the market are B. Braun Melsungen AG, Baxter International Inc., Coloplast AS, ConvaTec Group Plc, Hollister Inc., Becton, Dickinson and Co., Cardinal Health Inc., Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Kawasumi Laboratories Inc, among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the medical specialty bags market globally. For instance, in May 2019, B. Braun Medical has announced that it is investing $1 billion into new and existing IV fluid manufacturing facilities to address the IV solution shortage exacerbated by Hurricane Maria's making landfall in Puerto Rico.

Key Companies to Watch

B. Braun Melsungen AG

Overview: B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, and pain therapy products, as well as infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and ostomy, disinfection, and wound care products.

Product Portfolio: Flexima Uro Silk Flat Urostomy Bags- The Flexima Uro Silk convex urostomy bags are designed for people with flush or slightly retracted urostoma.

The global medical specialty bags market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market snippet by End-User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising surgical, dialysis, and blood transfusion procedures
    • 4.2.2. Growing geriatric population prone to urinary incontinence
  • 4.3. Restraints:
    • 4.3.1. Lack of reimbursement
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology
  • 5.3. Pipeline Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Unmet Needs

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 6.1.2. Market Attractiveness Index, By Product Segment
  • 6.2. Urinary Collection Bags*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Continuous ambulatory peritoneal dialysis (CAPD) bags
  • 6.4. Anesthesia breathing bags
  • 6.5. Blood bags
  • 6.6. Ostomy collection bags
    • 6.6.1. Single-use bags
    • 6.6.2. Multiple-use bags
  • 6.7. Enteral feeding bags
  • 6.8. Bile collection bags
  • 6.9. Sterile packaging bags
  • 6.10. Resuscitation bags
    • 6.10.1. Disposable bags
    • 6.10.2. Reusable bags
  • 6.11. Intravenous (IV) fluid bags
    • 6.11.1. PVC material based fluid bags
    • 6.11.2. Non- PVC material based fluid bags
  • 6.12. Cadaver bags
  • 6.13. Enema bags
  • 6.14. Ice bags

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 7.1.2. Market Attractiveness Index, By End-User Segment
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Centers
  • 7.4. Healthcare centers
  • 7.5. Home Healthcare
  • 7.6. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. The U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. The Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. B. Braun Melsungen AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Baxter International Inc.
  • 10.3. Coloplast AS
  • 10.4. ConvaTec Group Plc
  • 10.5. Hollister Inc.
  • 10.6. Becton, Dickinson, and Co.
  • 10.7. Cardinal Health Inc.
  • 10.8. Fresenius Medical Care AG & Co. KGaA
  • 10.9. Terumo Corporation
  • 10.10. Kawasumi Laboratories Inc (List Not Exhaustive)

11. DataM Intelligence

  • 11.1. Appendix
  • 11.2. About Us and Services
  • 11.3. Contact Us